How Analysts Feel About Quidel Corporation (NASDAQ:QDEL)?

April 23, 2018 - By Maria Brooks

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.03, from 1.2 in 2017Q3. It dived, as 18 investors sold Quidel Corporation shares while 35 reduced holdings. 27 funds opened positions while 35 raised stakes. 30.94 million shares or 0.83% more from 30.68 million shares in 2017Q3 were reported.
Cubist Systematic Strategies Llc has 6,336 shares for 0.01% of their portfolio. Bnp Paribas Arbitrage stated it has 6,054 shares or 0% of all its holdings. 9,418 were accumulated by Hsbc Holdg Pcl. Mesirow Fincl holds 1.14% or 371,245 shares in its portfolio. Obermeyer Wood Invest Counsel Lllp has invested 0.08% in Quidel Corporation (NASDAQ:QDEL). Blackrock accumulated 1.79M shares or 0% of the stock. Alliancebernstein Ltd Partnership reported 42,549 shares stake. York Cap Mgmt Glob Ltd Limited Liability Company stated it has 0.13% in Quidel Corporation (NASDAQ:QDEL). Nelson Roberts Advsr Ltd Liability Com holds 0% or 300 shares in its portfolio. 579,709 are owned by Millennium Ltd Company. Eam Invsts Ltd Liability Co owns 45,737 shares or 0.26% of their US portfolio. Lazard Asset Mgmt reported 14,397 shares. Acadian Asset Management Lc holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 7,671 shares. 65,208 were reported by First Advisors L P. Zebra Cap Management Ltd Company holds 0.15% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 10,049 shares.

Since October 27, 2017, it had 0 buys, and 10 sales for $15.28 million activity. Another trade for 36,000 shares valued at $1.86M was sold by BRYANT DOUGLAS C. STEWARD RANDALL J sold 36,383 shares worth $1.46 million. Another trade for 110,704 shares valued at $4.40 million was made by Bujarski Robert Joseph on Friday, December 15. BORKAR RATAN S also sold $1.35 million worth of Quidel Corporation (NASDAQ:QDEL) shares. 16,358 shares valued at $661,529 were sold by Kroll Werner on Friday, December 8.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 8 analysts covering Quidel Corp (NASDAQ:QDEL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel Corp had 13 analyst reports since October 24, 2017 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and $52.0 target in Tuesday, January 2 report. The stock of Quidel Corporation (NASDAQ:QDEL) has “Overweight” rating given on Monday, April 2 by Barclays Capital. The stock of Quidel Corporation (NASDAQ:QDEL) has “Buy” rating given on Thursday, December 21 by Canaccord Genuity. The company was maintained on Tuesday, October 24 by Canaccord Genuity. Barclays Capital maintained the stock with “Buy” rating in Monday, January 22 report. The stock of Quidel Corporation (NASDAQ:QDEL) has “Buy” rating given on Monday, March 26 by Craig Hallum. The rating was maintained by Barclays Capital with “Overweight” on Thursday, November 2. The firm has “Buy” rating given on Thursday, January 4 by C.L. King. The firm earned “Strong Buy” rating on Thursday, March 8 by Raymond James. Canaccord Genuity maintained the shares of QDEL in report on Thursday, April 5 with “Buy” rating. Below is a list of Quidel Corporation (NASDAQ:QDEL) latest ratings and price target changes.

13/04/2018 Broker: William Blair Rating: Buy Maintain
05/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $64.0000 Maintain
03/04/2018 Broker: Piper Jaffray Rating: Buy New Target: $63.0000 Maintain
02/04/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $60 New Target: $63 Maintain
26/03/2018 Broker: Craig Hallum Rating: Buy New Target: $62.0000 Initiate
08/03/2018 Broker: Raymond James Old Rating: Outperform New Rating: Strong Buy Old Target: $47 Upgrade
22/01/2018 Broker: Barclays Capital Rating: Buy New Target: $60.0 Maintain
04/01/2018 Broker: CL King Old Rating: Neutral New Rating: Buy Upgrade
04/01/2018 Broker: C.L. King Rating: Buy Upgrade
02/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $52.0 Maintain

The stock decreased 0.52% or $0.29 during the last trading session, reaching $55.32. About 9,522 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 128.16% since April 23, 2017 and is uptrending. It has outperformed by 116.61% the S&P500.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC womenÂ’s and general health, and gastrointestinal diseases. The company has market cap of $2.06 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It currently has negative earnings. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: